It is reported that Vabysmo and Spinal Muscular Atrophy Evrysdi Dry Syrup 0.75mg/mL will be listed on the benefit in October. Additionally, the upper limit for 2 Jardiance items and 2 Ninlaro items is expected to be reduced due to PVA. It is reported that the upper limit price of pseudoephedrine ingredient preparations that have completed negotiations will be adjusted to 29 to 32 won as a condition of supply expansion.

According to the industry on the 21st, the government is pushing for such revisions to the drug list. It is expected to take effect as early as September 1. Vabysmo passed the HIRA Pharmaceutical Reimbursement Evaluation Committee last July. It is said that at the time of passage, the up